Literature DB >> 6817773

Antagonism of the central effects of 3-methylclonazepam.

A Darragh, R Lambe, I Brick, C O'Boyle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6817773      PMCID: PMC1427549          DOI: 10.1111/j.1365-2125.1982.tb02052.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  The residual effects of flurazepam.

Authors:  A J Bond; M H Lader
Journal:  Psychopharmacologia       Date:  1973-09-28

2.  Investigation in man of the efficacy of a benzodiazepine antagonist, Ro 15-1788.

Authors:  A Darragh; R Lambe; M Scully; I Brick; C O'Boyle; W W Downe
Journal:  Lancet       Date:  1981-07-04       Impact factor: 79.321

3.  Agonist and antagonist benzodiazepine receptor interaction in vitro.

Authors:  H Möhler; J G Richards
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

4.  RO 15-1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability.

Authors:  A Darragh; R Lambe; M Kenny; I Brick; W Taaffe; C O'Boyle
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

5.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

  5 in total
  5 in total

1.  The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects.

Authors:  A Higgitt; M Lader; P Fonagy
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Identifying Metabolites of Meclonazepam by High-Resolution Mass Spectrometry Using Human Liver Microsomes, Hepatocytes, a Mouse Model, and Authentic Urine Samples.

Authors:  Svante Vikingsson; Ariane Wohlfarth; Mikael Andersson; Henrik Gréen; Markus Roman; Martin Josefsson; Fredrik C Kugelberg; Robert Kronstrand
Journal:  AAPS J       Date:  2017-01-13       Impact factor: 4.009

3.  Central effects in man of the novel schistosomicidal benzodiazepine meclonazepam.

Authors:  C O'Boyle; R Lambe; A Darragh
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 4.  Pharmacokinetics and clinical use of flumazenil (Ro 15-1788).

Authors:  U Klotz; J Kanto
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447

5.  Non-sedating benzodiazepines cause paralysis and tissue damage in the parasitic blood fluke Schistosoma mansoni.

Authors:  Paul McCusker; Md Yeunus Mian; Guanguan Li; Michael D Olp; V V N Phani Babu Tiruveedhula; Farjana Rashid; Lalit Kumar Golani; Ranjit S Verma; Brian C Smith; James M Cook; John D Chan
Journal:  PLoS Negl Trop Dis       Date:  2019-11-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.